Source:http://linkedlifedata.com/resource/pubmed/id/18799104
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2008-9-18
|
pubmed:abstractText |
Sulphasalazine, one of the 5-amino-salicylates, is widely used for the treatment of inflammatory bowel diseases and arthritis. Among the reported adverse effects are blood dyscrasias and hepatic failure. Peripheral neuropathy has been reported as a rare adverse drug reaction to sulphasalazine. Most reported patients developed symptoms several weeks after onset of treatment. We describe a patient with an axonal polyneuropathy that occurred after two years of treatment with sulphasalazine.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0392-856X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
26
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
671-2
|
pubmed:meshHeading |
pubmed-meshheading:18799104-Adult,
pubmed-meshheading:18799104-Anti-Inflammatory Agents, Non-Steroidal,
pubmed-meshheading:18799104-Drug Administration Schedule,
pubmed-meshheading:18799104-Female,
pubmed-meshheading:18799104-Humans,
pubmed-meshheading:18799104-Neurotoxicity Syndromes,
pubmed-meshheading:18799104-Polyneuropathies,
pubmed-meshheading:18799104-Spondylarthropathies,
pubmed-meshheading:18799104-Sulfasalazine,
pubmed-meshheading:18799104-Young Adult
|
pubmed:articleTitle |
Axonal neuropathy with prolonged sulphasalazine use.
|
pubmed:affiliation |
Department of Neurology and the Department of Rheumatology, V.U. University Medical Centre, Amsterdam, The Netherlands. m.liedorp@vumc.nl
|
pubmed:publicationType |
Journal Article,
Case Reports
|